PortfoliosLab logoPortfoliosLab logo
IMVT vs. NARI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IMVT vs. NARI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immunovant, Inc. (IMVT) and Inari Medical, Inc. (NARI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


IMVT

1D
0.74%
1M
11.85%
YTD
22.54%
6M
37.16%
1Y
101.75%
3Y*
14.67%
5Y*
25.69%
10Y*

NARI

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IMVT vs. NARI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
IMVT
Immunovant, Inc.
22.54%2.62%-41.21%137.35%108.33%-81.55%130.83%
NARI
Inari Medical, Inc.
0.00%56.65%-21.36%2.14%-30.36%4.56%105.34%

Correlation

The correlation between IMVT and NARI is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (All Time)
Calculated using the full available price history since May 26, 2020

0.18

Fundamentals

Total Revenue (TTM)

IMVT:

$0.00

NARI:

$574.50M

Gross Profit (TTM)

IMVT:

-$206.00K

NARI:

$494.08M

EBITDA (TTM)

IMVT:

-$527.21M

NARI:

-$36.16M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Immunovant, Inc.

Inari Medical, Inc.

Return for Risk

IMVT vs. NARI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMVT
IMVT Risk / Return Rank: 8686
Overall Rank
IMVT Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
IMVT Sortino Ratio Rank: 8787
Sortino Ratio Rank
IMVT Omega Ratio Rank: 8181
Omega Ratio Rank
IMVT Calmar Ratio Rank: 9191
Calmar Ratio Rank
IMVT Martin Ratio Rank: 8989
Martin Ratio Rank

NARI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMVT vs. NARI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immunovant, Inc. (IMVT) and Inari Medical, Inc. (NARI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IMVTNARIDifference

Sharpe ratio

Return per unit of total volatility

1.64

Sortino ratio

Return per unit of downside risk

2.92

Omega ratio

Gain probability vs. loss probability

1.32

Calmar ratio

Return relative to maximum drawdown

4.88

Martin ratio

Return relative to average drawdown

11.26

IMVT vs. NARI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


IMVTNARIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.64

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.35

Sharpe Ratio (All Time)

Calculated using the full available price history

0.14

Drawdowns

IMVT vs. NARI - Drawdown Comparison


Loading charts...

Drawdown Indicators


IMVTNARIDifference

Max Drawdown

Largest peak-to-trough decline

-93.59%

Max Drawdown (1Y)

Largest decline over 1 year

-20.98%

Max Drawdown (3Y)

Largest decline over 3 years

-69.88%

Max Drawdown (5Y)

Largest decline over 5 years

-70.38%

Current Drawdown

Current decline from peak

-40.90%

Average Drawdown

Average peak-to-trough decline

-54.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.07%

Volatility

IMVT vs. NARI - Volatility Comparison


Loading charts...

Volatility by Period


IMVTNARIDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.78%

Volatility (6M)

Calculated over the trailing 6-month period

44.71%

Volatility (1Y)

Calculated over the trailing 1-year period

62.24%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.28%

Dividends

IMVT vs. NARI - Dividend Comparison

Neither IMVT nor NARI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

IMVT vs. NARI - Financials Comparison

This section allows you to compare key financial metrics between Immunovant, Inc. and Inari Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M202220232024202520260
153.39M
(IMVT) Total Revenue
(NARI) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IMVT and NARI have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for IMVT and NARI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer